Skip to main content

Matrixyl vs GHRP-2

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Matrixyl

Matrixyl (Palmitoyl Pentapeptide-4) is a signal peptide that stimulates collagen and extracellular matrix production. It is one of the most well-studied anti-aging peptides with proven efficacy for wrinkle reduction.

Full details →

GHRP-2

Growth Hormone Releasing Peptide 2 (GHRP-2) is considered one of the most potent GHRPs available. It provides strong GH release with moderate hunger increase compared to GHRP-6.

Full details →

Side-by-Side Comparison

AspectMatrixylGHRP-2
MechanismMimics collagen breakdown fragments, triggering fibroblasts to produce new collagen, elastin, and other matrix components. Essentially tricks skin into repair mode without actual damage.Binds to the ghrelin receptor (GHS-R) to stimulate GH release from the pituitary. Also has some direct effects on the hypothalamus. Causes less appetite increase than GHRP-6.
Typical DosageTopical: 2-8% concentration in serums and creams. Matrixyl 3000 combines it with Palmitoyl Tetrapeptide-7 for enhanced effects.Typical dosing: 100-300mcg administered 2-3 times daily. Often stacked with GHRH peptides for enhanced GH release.
AdministrationTopical application 1-2 times daily. Can be combined with other actives like retinol, vitamin C, and other peptides.Subcutaneous injection on an empty stomach. Can be used at bedtime to enhance natural GH pulse during sleep.
Side EffectsVery well-tolerated. Rare mild irritation. Suitable for sensitive skin types.Moderate hunger increase, water retention, potential prolactin and cortisol elevation (less than GHRP-6), tingling sensations.
Best For

Key Differences

Detailed Analysis

GHRP-2 and Matrixyl are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose GHRP-2 for Muscle Growth, Fat Loss, Sleep Quality. Choose Matrixyl for Anti-Aging & Longevity, Skin Health & Aesthetics.

Ready to Learn More?